| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10165604 | Mayo Clinic Proceedings | 2014 | 15 Pages |
Abstract
On the basis of network meta-analysis, IFX may be most efficacious agent for inducing remission in CD in biologic-naïve patients. In the absence of head-to-head treatment comparison, the confidence in these estimates is low. Future comparative efficacy studies are warranted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Siddharth MD, Sushil Kumar MBBS, Darrell S. MD, MS, Zhen PhD, Mohammad MD, MPH, Edward V. MD,